Treatment(s) already received-Chemotherapy - Page 11 of 16 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Chemotherapy Posts on Medivizor

Afatinib versus erlotinib: Comparing two second-line treatments for advanced squamous cell carcinoma

Afatinib versus erlotinib: Comparing two second-line treatments for advanced squamous cell carcinoma

Posted by on Jul 25, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of afatinib (Gilotrif) and erlotinib (Tarceva) as second-line treatments for advanced squamous cell carcinoma (SCC). Authors reported improved survival and disease progression with afatinib compared to erlotinib. Both treatments were associated with a good safety profile. Some background...

Read More

Role of stereotactic body radiotherapy in patients with positive margins after rectal cancer surgery

Role of stereotactic body radiotherapy in patients with positive margins after rectal cancer surgery

Posted by on Jul 11, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the role of stereotactic body radiotherapy (SBRT) in patients with positive margins (when the cancer is not totally removed) after chemotherapy, radiation therapy and rectal surgery. Researchers suggested that SBRT is an effective and safe treatment option. Some background Chemotherapy and radiation therapy...

Read More

Re-evaluation of the tumor is beneficial for treatment planning in advanced rectal cancer patients

Re-evaluation of the tumor is beneficial for treatment planning in advanced rectal cancer patients

Posted by on Jun 27, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the necessity of re-evaluation of locally advanced tumors (spread to the lymph nodes) after chemotherapy and radiation therapy. Researchers reported that re-evaluation is important to better plan treatment.  Some background Chemotherapy and radiation therapy (CTRT) followed by surgery is the standard...

Read More

A combination of surgery and chemotherapy increases survival in stage 4 colorectal cancer

A combination of surgery and chemotherapy increases survival in stage 4 colorectal cancer

Posted by on Jun 3, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of surgery in patients with stage 4 (spread to other areas of the body) colorectal cancer who were treated with chemotherapy. Researchers reported that surgery increased survival in these patients.  Some background Prior studies have reported increased survival in patients with stage 4...

Read More

Palbociclib therapy for metastatic breast cancer

Palbociclib therapy for metastatic breast cancer

Posted by on Apr 11, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine if palbociclib (Ibrance) could help treat women with metastatic (spread to other areas of the body) breast cancer. The researchers concluded that palbociclib showed good response rates from women with metastatic breast cancer whose cells expressed a protein called retinoblastoma (Rb). Some background...

Read More

A combination of afatinib and paclitaxel in EGFR-mutant non-small cell lung cancer

A combination of afatinib and paclitaxel in EGFR-mutant non-small cell lung cancer

Posted by on Feb 7, 2016 in Lung cancer | 1 comment

In a nutshell This study aimed to determine the efficacy of a combination of the anticancer drugs afatinib (Gilotrif) and paclitaxel (Taxol) to treat non-small cell lung cancer (NSCLC), compared to chemotherapy alone. The study found that a combination of these drugs significantly improved progression free survival (PFS, time from treatment until...

Read More